Compare NBIX & BURL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBIX | BURL |
|---|---|---|
| Founded | 1992 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 16.0B |
| IPO Year | 1996 | 2013 |
| Metric | NBIX | BURL |
|---|---|---|
| Price | $157.22 | $231.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 22 | 16 |
| Target Price | $180.91 | ★ $355.29 |
| AVG Volume (30 Days) | 949.8K | ★ 1.7M |
| Earning Date | 05-05-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.95 | 21.92 |
| EPS | 3.30 | ★ 4.67 |
| Revenue | $161,626,000.00 | ★ $11,566,910,000.00 |
| Revenue This Year | $24.73 | $12.72 |
| Revenue Next Year | $13.14 | $8.47 |
| P/E Ratio | ★ $47.34 | $51.19 |
| Revenue Growth | ★ 977.51 | 8.76 |
| 52 Week Low | $122.14 | $236.28 |
| 52 Week High | $186.12 | $378.33 |
| Indicator | NBIX | BURL |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 18.98 |
| Support Level | $152.67 | N/A |
| Resistance Level | $161.00 | $317.57 |
| Average True Range (ATR) | 4.14 | 11.42 |
| MACD | 0.85 | -4.08 |
| Stochastic Oscillator | 84.92 | 0.48 |
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
Burlington Stores Inc is an off-price retailer offering an extensive selection of in-season, fashion-focused merchandise, including women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts, and coats. The company sells a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. It sells products in categories such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby, and Outerwear.